Clinical Trials on HER-2 Negative Breast Cancer

Total 8 results

  • NCT04464967
    Withdrawn
    Conditions: Advanced Solid Tumor, Metastatic Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER-2 Protein Overexpression, Esophageal Cancer, Ovarian Cancer, Endometrium Cancer, Bladder Cancer, Pancreatic Cancer, Colorectal Cancer, Non Small Cell Lung Cancer, EGF-R Positive Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer, Cervical Cancer, Sarcoma
  • NCT03462251
    Active, not recruiting
    Conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast Cancer
  • NCT02692755
    Active, not recruiting
    Conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
  • NCT01446159
    Completed
    Conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
  • NCT02598310
    Terminated
    Conditions: Breast Cancer, Estrogen Receptor Negative Neoplasm, HER-2 Positive Breast Cancer
  • NCT03799692
    Unknown status
    Conditions: HER-2 Negative Breast Cancer
  • NCT01677455
    Completed
    Conditions: Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer, ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment
  • NCT01548534
    Terminated
    Conditions: Metastatic Breast Cancer, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor, HER-2 Negative Tumor